Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 503321 - 503340 out of 504621 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01XG03) ixazomib | NINLARO 2.3MG CAP | 3 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XG03) ixazomib | NINLARO 2.3MG CAP | 3 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XG03) ixazomib | NINLARO 3MG CAP | 3 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XG03) ixazomib | NINLARO 3MG CAP | 3 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XG03) ixazomib | NINLARO 4MG CAP | 3 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XG03) ixazomib | NINLARO 4MG CAP | 3 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XH02) romidepsin | ROMIDEPSIN 27.5MG/5.5ML INJ | 5.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01XH02) romidepsin | ROMIDEPSIN 27.5MG/5.5ML INJ | 5.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01XJ03) glasdegib | DAURISMO 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerInc. |
| USA | (L01XJ03) glasdegib | DAURISMO 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerInc. |
| USA | (L01XJ03) glasdegib | DAURISMO 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerInc. |
| USA | (L01XJ03) glasdegib | DAURISMO 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
Pages
